Literature DB >> 2740350

Molecular cloning and primary structure of human glial fibrillary acidic protein.

S A Reeves1, L J Helman, A Allison, M A Israel.   

Abstract

Glial fibrillary acidic protein (GFAP) is an intermediate-filament (IF) protein that is highly specific for cells of astroglial lineage, although its tissue-specific role is speculative. Determination of the primary structure of this protein should be of importance for understanding the functional role it plays in astroglia. Therefore, we isolated a cDNA clone encoding this protein and determined its nucleotide sequence. The predicted amino acid sequence indicates that GFAP shares structural similarities--particularly in the central rod domain and to a lesser degree in the carboxyl-terminal domain--with other IF proteins found in nonepithelial cell types. Considerable sequence divergence in the amino-terminal region of GFAP suggests that the tissue-specific functions of this IF protein might be mediated through this region of the molecule. In contrast, conservation of structural characteristics and a moderate degree of sequence conservation in the carboxyl-terminal region suggest functional similarities. Blot hybridization analysis using the GFAP cDNA as a probe failed to detect GFAP mRNA in both normal and neoplastic human tissues in which IF proteins other than GFAP are known to be expressed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2740350      PMCID: PMC297581          DOI: 10.1073/pnas.86.13.5178

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

Review 1.  Nervous system specific proteins.

Authors:  E Bock
Journal:  J Neurochem       Date:  1978-01       Impact factor: 5.372

2.  Degradation of glial fibrillary acidic protein by a calcium dependent proteinase: an electroblot study.

Authors:  S J DeArmond; M Fajardo; S A Naughton; L F Eng
Journal:  Brain Res       Date:  1983-03-07       Impact factor: 3.252

3.  Intermediate filaments as mechanical integrators of cellular space.

Authors:  E Lazarides
Journal:  Nature       Date:  1980-01-17       Impact factor: 49.962

4.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

5.  Calcium-mediated breakdown of glial filaments and neurofilaments in rat optic nerve and spinal cord.

Authors:  W W Schlaepfer; U P Zimmerman
Journal:  Neurochem Res       Date:  1981-03       Impact factor: 3.996

6.  Amino acid sequences of alpha-helical segments from S-carboxymethylkerateine-A. Complete sequence of a type-II segment.

Authors:  W G Crewther; A S Inglis; N M McKern
Journal:  Biochem J       Date:  1978-08-01       Impact factor: 3.857

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Heterogeneity of Genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas.

Authors:  D D Bigner; S H Bigner; J Pontén; B Westermark; M S Mahaley; E Ruoslahti; H Herschman; L F Eng; C J Wikstrand
Journal:  J Neuropathol Exp Neurol       Date:  1981-05       Impact factor: 3.685

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

10.  Antibodies to neurofilament, glial filament, and fibroblast intermediate filament proteins bind to different cell types of the nervous system.

Authors:  S H Yen; K L Fields
Journal:  J Cell Biol       Date:  1981-01       Impact factor: 10.539

View more
  48 in total

1.  Identification of SLC38A7 (SNAT7) protein as a glutamine transporter expressed in neurons.

Authors:  Maria G A Hägglund; Smitha Sreedharan; Victor C O Nilsson; Jafar H A Shaik; Ingrid M Almkvist; Sofi Bäcklin; Orjan Wrange; Robert Fredriksson
Journal:  J Biol Chem       Date:  2011-04-21       Impact factor: 5.157

2.  Assessing self-renewal and differentiation in human embryonic stem cell lines.

Authors:  Jingli Cai; Jia Chen; Ying Liu; Takumi Miura; Yongquan Luo; Jeanne F Loring; William J Freed; Mahendra S Rao; Xianmin Zeng
Journal:  Stem Cells       Date:  2005-11-17       Impact factor: 6.277

Review 3.  GFAP and its role in Alexander disease.

Authors:  Roy A Quinlan; Michael Brenner; James E Goldman; Albee Messing
Journal:  Exp Cell Res       Date:  2007-04-06       Impact factor: 3.905

4.  Free left arms as precursor molecules in the evolution of Alu sequences.

Authors:  J Jurka; E Zuckerkandl
Journal:  J Mol Evol       Date:  1991-07       Impact factor: 2.395

5.  Identification of a novel nonsense mutation in the rod domain of GFAP that is associated with Alexander disease.

Authors:  Tai-Seung Nam; Jin Hee Kim; Chi-Hsuan Chang; Woong Yoon; Yoon Seok Jung; Sa-Yoon Kang; Boo Ahn Shin; Ming-Der Perng; Seok-Yong Choi; Myeong-Kyu Kim
Journal:  Eur J Hum Genet       Date:  2014-04-23       Impact factor: 4.246

Review 6.  Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker.

Authors:  Zhihui Yang; Kevin K W Wang
Journal:  Trends Neurosci       Date:  2015-05-11       Impact factor: 13.837

7.  The neuroinvasive profiles of H129 (herpes simplex virus type 1) recombinants with putative anterograde-only transneuronal spread properties.

Authors:  Gregory J Wojaczynski; Esteban A Engel; Karina E Steren; Lynn W Enquist; J Patrick Card
Journal:  Brain Struct Funct       Date:  2014-03-02       Impact factor: 3.270

8.  Suppression of glial tumor growth by expression of glial fibrillary acidic protein.

Authors:  M Toda; M Miura; H Asou; I Sugiyama; T Kawase; K Uyemura
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

9.  Fgf-2 in astroglial cells during vertebrate spinal cord recovery.

Authors:  Gehan H Fahmy; Marie Z Moftah
Journal:  Front Cell Neurosci       Date:  2010-11-04       Impact factor: 5.505

10.  EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation.

Authors:  Günther H S Richter; Stephanie Plehm; Annette Fasan; Sabine Rössler; Rebekka Unland; Idriss M Bennani-Baiti; Marc Hotfilder; Diana Löwel; Irene von Luettichau; Ilona Mossbrugger; Leticia Quintanilla-Martinez; Heinrich Kovar; Martin S Staege; Carsten Müller-Tidow; Stefan Burdach
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.